Euroapi (XPAR:EAPI) Non Operating Income: €0.0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:EAPI Euroapi SA XPAR:EAPI
54 GF Score
Price €1.28
GF Value €2.88
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Euroapi Non Operating Income?

Euroapi XPAR:EAPI +1.75% 54 Non Operating Income is €0.0 Mil as of Dec. 2025. GuruFocus rates XPAR:EAPI with a GF Score™ of 54/100 and a GF Value™ of €2.88 (Possible Value Trap). The stock has 6 warning signs investors should review.

Non Operating Income is income or expense that comes from miscellaneous sources. Euroapi's Non Operating Income for the six months ended in Dec. 2025 was €0.0 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was €0.0 Mil.

Euroapi Non Operating Income Related Terms

Euroapi Non Operating Income Historical Data

* Premium members only.

The historical data trend for Euroapi's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Euroapi Non Operating Income Chart

Euroapi Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Non Operating Income
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Euroapi Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XPAR:EAPI
54GF Score
Euroapi SA XPAR:EAPI
Non Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Euroapi Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Non Operating Income →
What does a Non Operating Income of €0.0 Mil mean?
Euroapi (XPAR:EAPI) has a Non Operating Income of €0.0 Mil as of Dec. 2025. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Euroapi and its competitors.
Is Euroapi's Non Operating Income too high?
Euroapi's current Non Operating Income is €0.0 Mil. Overall, Euroapi has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Euroapi's Non Operating Income compare to ZTS and UTHR?
Euroapi's Non Operating Income of €0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Non Operating Income for a Drug Manufacturers company?
A good Non Operating Income depends on the Drug Manufacturers industry context. However, Non Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Non Operating Income mean?
A high Non Operating Income can signal that a stock is expensive relative to its fundamentals. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Euroapi and its competitors. Euroapi's current Non Operating Income is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euroapi stock overvalued right now?
Based on GuruFocus' analysis, Euroapi (XPAR:EAPI) is currently considered Possible Value Trap. The stock's GF Value™ is €2.88, compared to a current price of €1.28 — trading 55.6% below its estimated fair value. The current Non Operating Income is €0.0 Mil. Euroapi's overall GF Score™ is 54/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Non Operating Income calculated?
Non Operating Income is calculated from a company's financial statements. For Euroapi (XPAR:EAPI), the current Non Operating Income is €0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Euroapi (XPAR:EAPI) Overvalued in 2026?

Based on GuruFocus' analysis, Euroapi stock appears to be undervalued. The current stock price of €1.28 is trading 55.6% below its estimated GF Value™ of €2.88. GuruFocus considers Euroapi to be Possible Value Trap.

Key valuation signals for XPAR:EAPI:

  • Non Operating Income: €0.0 Mil
  • GF Value™: €2.88 vs. price of €1.28 (55.6% below fair value)
  • GF Score™: 54/100 with 6 warning signs

No single metric tells the full story. See the XPAR:EAPI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Euroapi Business Description

Other Exchanges EAPIF:USA0EAP:UK940:Germany
Address 32 rue Alexandre Duma, Paris, FRA, 75011
Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates, analgesics, and others. It also offers Contract Development Manufacturing Organization (CDMO) services to its customers.
54GF Score

Get the complete analysis for XPAR:EAPI

Non Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.28
Price
€2.88
GF Value